Drug policy: let's maintain pressure on regulatory authorities
Prescrire International 22(137): 107
2013
ISSN/ISBN: 1167-7422 PMID: 23662324 Document Number: 670474
Document emailed within 1 workday
Related Documents
Farquharson, G.J. 1988: Working with the U.K. regulatory authorities Journal of Parenteral Science and Technology: a Publication of the Parenteral Drug Association 42(3): 85-88Bates, J.A. 1975: Analytical requirements of pesticides regulatory authorities Environmental Quality and Safety. Supplement 3: 75-79
Bergen-Cico, D 2013: Perspectives of U.S. Drug Policy: Observations and Advice From Drug Policy Administrators in Emerging Democracies in Central and Eastern Europe World Medical and Health Policy 5(4): 362-388
Horwitz, W.; Albert, R.H. 1985: Performance characteristics of methods of analysis used for regulatory purposes. I. Drug dosage forms. D. High pressure liquid chromatographic methods Journal - Association of Official Analytical Chemists 68(2): 191-198
Chocarro, L.; Duclos, P.; Senouci, K.; Southern, J. 2011: Consultation on interactions between National Regulatory Authorities and National Immunization Technical Advisory Groups Expert Review of Vaccines 10(9): 1265-1270
Lund, E. 2016: Local and Regional Authorities as Resources for Implementing Universal Design Policy in Norway Studies in Health Technology and Informatics 229: 63-68
Jackson, J.; Meisinger, J.; Patel, S.; Lim, Z.C.; Vellody, K.; Metz, R.; Young, M.R. 1997: Protein phosphatase-2A associates with the cytoskeleton to maintain cell spreading and reduced motility of nonmetastatic Lewis lung carcinoma cells: the loss of this regulatory control in metastatic cells Invasion and Metastasis 17(4): 199-209
Karadsheh, M.J.; Nelson, J.; Wilcox, R. 2015: The Application of Skin Adhesive to Maintain Seal in Negative Pressure Wound Therapy Wounds: a Compendium of Clinical Research and Practice 27(9): 244-248
Gulotta, T.; Castello, G.; Angelo, F. 1980: Use of althesin as a drug to induce and maintain anesthesia for cesarean section Minerva Anestesiologica 46(2): 293-296
Waterlow, J. 1991: A policy that protects. The Waterlow Pressure Sore Prevention/Treatment Policy Professional Nurse 6(5): 258 260 262-4
Wilson, P. 1989: Brookings dialogues on public policy. Toward a national policy on drug and aids testing Health Policy 13(3): 253-254
Ritter, A. 2011: Ensuring the policy relevance of population health research: experiences from the Drug Policy Modelling Program New South Wales Public Health Bulletin 22(1-2): 19-22
Guyon, A'ingabe. 2012: Intensify the development of public policy has the health: approaches strategic for the authorities of health public Canadian Journal of Public Health 103(6): E459-E461
Diaconu, C.C.; Neagu, A.I.; Lungu, Răzvan.; Tardei, Gţiela.; Alexiu, I.; Bleotu, C.; Economescu, M.Chivu.; Bumbăcea, R.S.; Pele, I.; Bumbăcea, Dş. 2010: Plasticity of regulatory T cells under cytokine pressure Roumanian Archives of Microbiology and Immunology 69(4): 190-196
Brownbridge, M. 1998: Financial Distress in Local Banks in Kenya, Nigeria, Uganda and Zambia: Causes and Implications for Regulatory Policy Development Policy Review 16(2): 173-188
Luo, X-J.; Zheng, M.; Tian, G.; Zhong, H-Y.; Zou, X-J.; Jian, D-L. 2016: Comparison of the treatment effects of methoxamine and combining methoxamine with atropine infusion to maintain blood pressure during spinal anesthesia for cesarean delivery: a double blind randomized trial European Review for Medical and Pharmacological Sciences 20(3): 561-567
Page, J.Bryan. 2005: International research and local authorities: Interplay between research and police agendas in the field of drug abuse and AIDS Journal of Urban Health: Bulletin of the new York Academy of Medicine 82(3 Suppl 4): Iv16-Iv23
Kamya, M.R.; Bakyaita, N.N.; Talisuna, A.O.; Were, W.M.; Staedke, S.G. 2002: Increasing antimalarial drug resistance in Uganda and revision of the national drug policy Tropical Medicine and International Health: Tm and Ih 7(12): 1031-1041
Rastad, J.A.; Klintberg, K.; Von Bahr, C. 1996: The licence drug policy of the Medical Drug Agency. Permitted use in special needs Lakartidningen 93(47): 4309-4310
Jayasuriya, L. 2000: The drug regulatory authority Ceylon Medical Journal 45(2): 87-88